Filing Flows › Fennec Pharmaceuticals (FENC) › R&D spending
Fennec Pharmaceuticals (FENC) R&D spending by quarter
Fennec Pharmaceuticals' R&D spending was $118K in Q2 2026 (second quarter 2026), +141% from Q1 2026. Over the last 7 quarters it ranged from $20K (Q4 2025) to $118K (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $118K | +141% | +10% |
| Q1 2026 | $49K | +145% | -48% |
| Q4 2025 | $20K | -31% | -60% |
| Q3 2025 | $29K | -73% | — |
| Q2 2025 | $107K | +14% | — |
| Q1 2025 | $94K | +88% | — |
| Q4 2024 | $50K | — | — |
Q2 2026 at a glance
Fennec Pharmaceuticals, Q2 2026: revenue $17.9M (+85% year over year), operating margin 9.7%, net earnings $2.0M, operating cash flow $50K. The chart follows the revenue to costs, profit and cash.
Questions
What is Fennec Pharmaceuticals' R&D spending?
Fennec Pharmaceuticals' R&D spending was $118K in Q2 2026 (second quarter 2026), +141% from Q1 2026.
How has Fennec Pharmaceuticals' R&D spending changed?
Over the last 7 quarters it ranged from $20K (Q4 2025) to $118K (Q2 2026).
Q2 2026 results → · How Fennec Pharmaceuticals makes money →